Market Tracker

05/26 5:28am ET

Vanguard Health Care Index Fund ETF Shares (VHT)

129.21
Delayed Data
As of May 25
 +0.87 / +0.68%
Today’s Change
91.31
Today|||52-Week Range
146.00
-2.76%
Year-to-Date

Investment Objective

The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.

3 Healthcare Stocks Bears Are Wrong About
May 18 / MotleyFool.com - Paid Partner Content
 

Performance

1 month-2.19% 3 years+14.64%
3 months+6.97% 5 years+16.57%
1 year-6.62% Since inception+9.31%
Data through 05/25/2016

Quote Details

Previous close$128.34
Open day’s range128.62 – 129.42
Net asset value (NAV)128.35 (05/24/2016)
Daily volume119,629
Average volume (3 months)238,258
Data as of 05/25/2016

Peer Comparisonvs. Health ETFs

 VHTCategory
Performance 5-yr return+16.57%+15.78%
Expense Gross exp ratio0.09%0.47%
Risk 5 year sharpe ratio1.260.97
Net assets$6.2B$1.3B
Average market cap$49.5B$27.9B
Average P/E23.624.4
Dividend / Share--0.22%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
IHI iShares U.S. Medical Devices ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 97.05%
Hardware 1.62%
Business service 0.22%
Financial service 0.05%
Consumer service 0.02%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson10.04%
PFE Pfizer6.53%
MRK Merck4.96%
GILD Gilead Sciences4.11%
UNH UnitedHealth4.06%
BMY Bristol-Myers Squibb3.90%
AMGN Amgen3.86%
MDT Medtronic PLC3.62%
ABBV AbbVie3.23%
AGN Allergan2.76%